Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Multiomics Enabled by Sequential Extraction for Comprehensive Molecular Profiling of Small Extracellular Vesicles.

Analytical chemistry·2026
Same author

Leveraging nanoparticle protein corona to advance plasma proteome profiling.

Nature communications·2026
Same author

Human plasma-like medium enhances structural and metabolic maturation of human pluripotent stem cell-derived cardiomyocytes.

Bioengineering & translational medicine·2026
Same author

Consensus statement on mass spectrometry-based proteomic analysis of cardiac tissue.

Nature cardiovascular research·2026
Same author

Differential Metabolic Changes in Zebrafish Embryos Are Induced by Discontinued Citalopram Exposure.

Biomedicines·2026
Same author

Integrated Multi-Omics Enabled by Sequential Extraction for Comprehensive Molecular Profiling of Small Extracellular Vesicles.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 9, 2026

Quantitative Analysis of Chromatin Proteomes in Disease
08:11

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

13.1K

Global Proteomic Analysis Reveals Alterations in Differentially Expressed Proteins between Cardiopathic Lamin A/C

Corey L Anderson1, Kyle A Brown2, Ryan J North1

  • 1Department of Medicine, Division of Cardiovascular Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.

Journal of Proteome Research
|May 8, 2024
PubMed
Summary

Lamin A/C (LMNA) mutations cause varied heart disease severity. Proteomics revealed distinct cellular changes for different LMNA mutations, offering personalized treatment insights for cardiac laminopathies.

Keywords:
cardiomyopathygenetic diseaselaminprotein aggregationproteomics

More Related Videos

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

8.6K
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

697

Related Experiment Videos

Last Updated: Jun 9, 2026

Quantitative Analysis of Chromatin Proteomes in Disease
08:11

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

13.1K
Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

8.6K
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

697

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Proteomics

Background:

  • Lamin A/C (LMNA) protein is crucial for nuclear lamina structure.
  • Mutations in LMNA lead to diverse cardiac conditions, including cardiomyopathy, heart failure, and sudden cardiac death.
  • The variability in LMNA mutation severity and onset is not well understood at the cellular level.

Purpose of the Study:

  • To investigate the cellular heterogeneity of LMNA-associated cardiomyopathy by comparing proteomic profiles of different LMNA variants.
  • To model the heterozygous state and represent diverse clinical LMNA mutations.
  • To identify mutation-specific downstream cellular effects for potential therapeutic targets.

Main Methods:

  • Overexpression of cardiopathic LMNA variants (Q353K, N195K, E317K) in HEK cells, including coexpression with wild-type (WT).
  • Quantitative proteomics to compare global protein expression profiles.
  • Bioinformatic analyses including differentially expressed proteins (DEPs), Gene Ontology (GO), and KEGG pathway analysis.
  • Functional validation using redox, autophagy, and apoptosis assays in HEK 293 cells and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs).

Main Results:

  • A range of 162 to 324 DEPs were identified across different LMNA mutation models.
  • Distinct differences in GO terms, KEGG pathways, and DEPs were observed, highlighting mutation-specific cellular impacts.
  • Disrupted pathways were validated through functional assays, confirming the cellular consequences of LMNA mutations.
  • Proteomic profiles revealed mutation-specific downstream effects relevant to cardiac function.

Conclusions:

  • Proteomic analysis of LMNA variants reveals significant heterogeneity in cellular responses, explaining variability in cardiac laminopathies.
  • These findings provide a foundation for understanding mutation-specific pathology.
  • The identified proteomic signatures and disrupted pathways offer potential druggable targets for personalized medicine approaches in cardiac laminopathies.